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Abstract
Metabolomics datasets are commonly acquired by either mass spectrometry (MS) or nuclear 
magnetic resonance spectroscopy (NMR), despite their fundamental complementarity. In fact, 
combining MS and NMR datasets greatly improves the coverage of the metabolome and enhances 
the accuracy of metabolite identification, providing a detailed and high-throughput analysis of 
metabolic changes due to disease, drug treatment, or a variety of other environmental stimuli. 
Ideally, a single metabolomics sample would be simultaneously used for both MS and NMR 
analyses, minimizing the potential for variability between the two datasets. This necessitates the 
optimization of sample preparation, data collection and data handling protocols to effectively 
integrate direct-infusion MS data with one-dimensional (1D) 1H NMR spectra. To achieve this 
goal, we report for the first time the optimization of (i) metabolomics sample preparation for dual 
analysis by NMR and MS, (ii) high throughput, positive-ion direct infusion electrospray ionization 
mass spectrometry (DI-ESI-MS) for the analysis of complex metabolite mixtures, and (iii) data 
handling protocols to simultaneously analyze DI-ESI-MS and 1D 1H NMR spectral data using 
multiblock bilinear factorizations, namely multiblock principal component analysis (MB-PCA) 
and multiblock partial least squares (MB-PLS). Finally, we demonstrate the combined use of 
backscaled loadings, accurate mass measurements and tandem MS experiments to identify 
metabolites significantly contributing to class separation in MB-PLS-DA scores. We show that 
integration of NMR and DI-ESI-MS datasets yields a substantial improvement in the analysis of 
neurotoxin involvement in dopaminergic cell death.
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INTRODUCTION
The analysis of metabolomics samples is routinely carried out using either mass 
spectrometry (MS) (Dettmer, Aronov, Hammock 2007) or nuclear magnetic resonance 
(NMR) spectroscopy (Nicholson, Lindon, Holmes 1999). However, NMR and MS have 
distinct, complementary sets of strengths and limitations. The advantages of NMR for 
metabolomics include relatively high-throughput, non-destructive data acquisition, minimal 
sample handling, simple methods for quantitation of metabolite alterations, and redundant 
spectral information to improve the accuracy of metabolite identification (Pan, Raftery 
2007; t’Kindt, Scheltema, Jankevics, Brunker, Rijal, Dujardin, Breitling et al. 2010; Zhang, 
Halouska, Gaupp, Lei, Snell, Fenton, Barletta et al. 2013). However, one-dimensional 
(1D) 1H NMR is limited by low sensitivity (≥ 1 μM), low information content (~0.02 ppm 
resolution over a ~10 ppm spectral width) and low dynamic range, all of which reduce the 
observable set of metabolites. These deficiencies of NMR are strengths of MS (Lenz, 
Wilson 2007; Pan, Raftery 2007). For instance, MS has a much higher sensitivity compared 
to NMR, readily measuring concentrations in the nanomolar (nM) range. MS also boasts 
higher resolution (~ 103 to 104) and dynamic range (~ 103 to 104). As a result, MS-based 
metabolomics studies can potentially detect a much greater subset of the metabolome than 
NMR.
More often than not, MS metabolomics relies on hyphenated analytical platforms, such as 
GC-MS (Kuehnbaum, Britz-McKibbin 2013) or LC-MS (Crockford, Holmes, Lindon, 
Plumb, Zirah, Bruce, Rainville et al. 2006), to reduce peak overlap and improve coverage of 
the metabolome. Peak overlap in the mass spectrum occurs because of the relatively narrow 
molecular-weight distribution of the metabolome (Kell 2004). Ion suppression is also a 
significant concern given the complexity and heterogeneity of metabolomics samples. The 
competition for charge between co-eluting analytes may lead to altered or missing 
metabolite signals (Metz, Page, Baker, Tang, Ding, Shen, Smith 2008). While the coupling 
of a chromatographic separation to MS potentially alleviates these issues, it also increases 
analysis time and requires additional sample preparation in comparison with NMR.
The extra sample processing required by chromatography may lead to variations in the 
observed metabolome not relevant to the biological system under study (Canelas, ten 
Pierick, Ras, Seifar, van Dam, van Gulik, Heijnen 2009). As an example, the chemical 
derivatization step required by GC-MS may individually bias metabolite concentrations. The 
derivatization yields may differ for each metabolite, and no derivatizing agent exists that 
will universally and efficiently label all metabolites in any given biological sample (Kanani, 
Chrysanthopoulos, Klapa 2008). Compound decomposition during derivatization or 
separation may also contribute to this bias (Xu, Zou, Ong 2009), and co-eluting matrix 
compounds may further suppress the ionization of true analytes in LC-MS (Taylor 2005). In 
fact, there is now a growing body of evidence suggesting that, with a judicious choice of 
instrumental conditions, direct infusion electrospray MS (DI-ESI-MS) may achieve equal or 
greater ion transmission efficiency in metabolic fingerprinting relative to LC-MS (Draper, 
Lloyd, Goodacre, Beckmann 2014). DI-ESI-MS requires less sample pre-treatment and 
allows for shorter instrument cycle times than LC-MS and GC-MS, and does not require 
post-acquisition alignment of retention times (Kopka 2006; Lange, Tautenhahn, Neumann, 
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Gropl 2008). Thus, DI-ESI-MS is an attractive choice of analytical platform to complement 
NMR for high-throughput metabolic fingerprinting and profiling.
Ion sources such as direct analysis in real time (DART) and desorption electrospray 
ionization (DESI) have also been utilized for MS analysis of metabolomics samples (Chen, 
Pan, Talaty, Raftery, Cooks 2006; Gu, Pan, Xi, Asiago, Musselman, Raftery 2011). DESI 
and DART are ambient ionization methods and provide an abundance of reproducible data 
(Chen, Pan, Talaty, Raftery, Cooks 2006; Gu, Pan, Xi, Asiago, Musselman, Raftery 2011). 
However, DESI and DART are not nearly as widely accessible as DI-ESI, which is nearly 
universally available in modern instrumentation facilities. DI-ESI-MS is also easily 
automated and can be performed with minimal sample preparation, which is indispensable to 
high-throughput studies (Draper, Lloyd, Goodacre, Beckmann 2014).
The combination of NMR and MS techniques for metabolic fingerprinting and profiling is a 
growing trend (Pan, Raftery 2007) and has been shown to improve metabolomics coverage 
(Barding, Beni, Fukao, Bailey-Serres, Larive 2013). A number of metabolomics studies 
combine 1D 1H NMR experiments with LC-MS (Atherton, Bailey, Zhang, Taylor, Major, 
Shockcor, Clarke et al. 2006; Jung, Jung, Kim, Ryu, Hwang 2013) or GC-MS (Barding, 
Beni, Fukao, Bailey-Serres, Larive 2013). In these cases, samples and data for each 
instrumental platform are handled in effective isolation. Most importantly, such studies 
require the preparation of separate sets of metabolite samples that meet the specific needs of 
NMR and MS instrumentation (Beltran, Suarez, Rodriguez, Vinaixa, Samino, Arola, Correig 
et al. 2012). Nevertheless, such parallel approaches greatly enhance the structural 
characterization and quantitation of metabolites (Dai, Xiao, Liu, Hao, Tang 2010). An 
alternative approach is to use MS as the primary analytical tool, relying on NMR to validate 
the results or confirm the identification of key metabolites (Mullen, Wheaton, Jin, Chen, 
Sullivan, Cheng, Yang et al. 2012). To date, a limited number of metabolomics studies 
actually integrate NMR spectral data with information obtained from direct infusion ion 
sources.
The combined multivariate statistical analysis of data from multiple instrumental platforms 
is a nascent and underutilized practice in the metabolomics field. Most studies that integrate 
NMR and DI-ESI-MS data still perform separate analyses of their respective data matrices 
and combine the results in an attempt to enhance the total information content. For example, 
Chen et al. performed independent principal component analyses (PCA) on NMR and MS 
datasets and combined the scores from each analysis into a three dimensional (3D) scores 
plot (Chen, Pan, Talaty, Raftery, Cooks 2006). While the resulting combined scores yielded 
greater between-class separations than the original NMR or MS scores, such an analysis 
completely ignores the highly informative correlations that exist between the two datasets. 
Similarly, Gu et al. (Gu, Pan, Xi, Asiago, Musselman, Raftery 2011) replaced binary class 
designations in an orthogonal projections to latent structures (OPLS) analysis of MS data 
with scores from a PCA of the corresponding NMR spectra. While the resulting OPLS-R 
class separations were greater than the original OPLS-DA separations, such an analysis 
carries no statistical guarantee of success for any other dataset.
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Multiblock bilinear factorizations such as Consensus PCA, Hierarchical PCA, Hierarchical 
PLS and Multiblock PLS provide a powerful framework for analyzing a set of multivariate 
observations from multiple analytical measurements containing potentially correlated 
variables (Smilde, Westerhuis, de Jong 2003; Westerhuis, Kourti, Macgregor 1998; Wold 
1987). Such algorithms provide analogous information to classical PCA and PLS in 
situations where extra knowledge is available to subdivide the measured variables into 
multiple “blocks”. As a result, the correlation structures of each block and the between-
block correlations may be simultaneously utilized. Due to the existence of trends common to 
each block, this use of between-block correlations during modeling will ideally bring the 
model loadings (latent variables) into better agreement with the true underlying biology 
(hidden variables). In short, multiblock algorithms provide an ideal means of integrating 
1D 1H NMR and DI-ESI-MS datasets for metabolic fingerprinting studies (Xu, Correa, 
Goodacre 2013).
The successful integration of DI-ESI-MS data with 1D 1H NMR data for metabolic 
fingerprinting and profiling necessitates improving sample preparation, data collection and 
data processing protocols. Our described optimization of sample preparation protocols 
enabled the utilization of a single sample for both NMR and MS analysis. To further 
diminish the impact of sample handling, samples were infused directly into the mass 
spectrometer without pre-source separation. Electrospray source conditions were then 
optimized in order to maximize the performance of DI-ESI-MS and minimize ion 
suppression and/or enhancement (matrix effects). Multiblock PCA (MB-PCA) and 
multiblock PLS (MB-PLS) were used to analyze the collected NMR and mass spectral data, 
allowing the identification of key metabolites that significantly contributed to class 
separation from the resulting scores and loadings. Finally, NMR, accurate mass and MS/MS 
data were collected to enhance the accuracy and efficiency of metabolite identification. Our 
resulting protocol for combining DI-ESI-MS with 1D 1H NMR for metabolic fingerprinting 
and profiling is summarized in Figure 1.
MATERIALS AND METHODS
Samples and reagents
All standard reagents and isotopically labeled chemicals were obtained from Sigma Aldrich 
(St. Loius, MO), Fischer Scientific (Fair Lawn, NJ) and Cambridge Isotopes (Andover, 
MA). A standard metabolite mixture was prepared by mixing six compounds together: 
caffeine, L-histidine, β-alanine, L-glutamine, (S)-(+)-ibuprofen, and L-asparagine at 
concentrations of 10 mM in double distilled water (ddH2O)/methanol/FA (49.75:49.75:0.5). 
The solution was diluted by a factor of 1000 for MS analysis. Metabolite extracts from 
Escherichia coli Mach1 were prepared as previously described in detail (Zhang, Halouska, 
Gaupp, Lei, Snell, Fenton, Barletta et al. 2013). To generate analytical replicates, each of the 
metabolite extracts were separated into three aliquots of 100 μL and then diluted ten-fold 
with ddH2O/methanol/FA (49.75:49.75:0.5) containing 10 μM caffeine as an internal mass 
reference. A complete description of the preparation of standard samples is available in the 
supporting information.
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Preparation of metabolomics samples from human dopaminergic neuroblastoma cells
Human dopaminergic neuroblastoma cells (SK-N-SH) with different neurotoxin treatments 
were used as a metabolomics test system for developing the methodology for integrating 
NMR and MS data. SK-N-SH cell lines were cultured in DMEM/F12 medium consisting of 
100 units/mL penicillin-streptomycin and 10% fetal bovine serum. 1.5×106 SK-N-SH cells 
were plated on a 10 cm dish for overnight incubation with 5% CO2 at 37 °C. The cells were 
then treated with 1-methyl-4-phenylpyridinium (MPP+), 50 μM 6-hydroxydopamine (6-
OHDA), 0.5 mM paraquat or 4.0 μM rotenone for 24 h. The cells were washed twice with 5 
mL PBS washes. 1.0 mL of cold methanol (−80 °C) was immediately added to 
simultaneously lyse and quench the cells, which were then incubated at −80 °C for 15 
minutes to facilitate cell lysis and metabolite extraction. The cells were detached from each 
dish using a cell scraper and cellular detachment was confirmed using an inverted 
microscope. The methanol and detached cell debris were transferred to 2.0 mL 
microcentrifuge tubes, which were centrifuged for five minutes at 15,294 g at 4 °C to 
separate the metabolite extract from the cell debris. The cell debris was then washed with 
500 μL of 80%/20% methanol/water and then with 500 μL of 100% ddH2O. Supernatants 
from each of the three extractions were finally combined into 2.0 mL microcentrifuge tubes.
Cell extract samples were then split into two portions: 1.8 mL for NMR analysis and 200 μL 
for MS analysis (Figure 1A). The MS portions were diluted tenfold with a solution of H2O/
methanol/FA (49.75:49.75:0.5) containing 20 μM reserpine as an internal mass reference. 
The NMR portions were placed in a RotoSpeed vacuum to remove the organic solvent, 
followed by freezing and lyophilization. Lyophilized NMR-bound metabolite extracts were 
then resuspended in 600 μL of 50 mM deuterated potassium phosphate buffer at pH 7.2 
(uncorrected) containing 50 μM of 3-(trimethylsilyl)propionic acid-2,2,3,3-d4 (TMSP-d4) 
and transferred to 5 mm NMR tubes.
NMR data acquisition and preprocessing
The NMR data was collected and processed according to our previously described protocol 
(Zhang, Halouska, Gaupp, Lei, Snell, Fenton, Barletta et al. 2013). A Bruker Avance DRX 
500 MHz spectrometer equipped with a 5 mm triple-resonance cryogenic probe 
(1H, 13C, 15N) with a z-axis gradient, BACS-120 sample changer, and an automatic tuning 
and matching accessory was utilized for automated NMR data collection.
Following acquisition, the 1D 1H NMR spectra were processed in our MVAPACK software 
suite (http://bionmr.unl.edu/mvapack.php), which provides a uniform data handling 
environment that is highly tuned for NMR chemometrics (Worley, Powers 2014a). A 1.0 Hz 
exponential apodization function and a single round of zero-filling were applied prior to 
Fourier transformation. Spectra were then automatically phased and normalized using phase-
scatter correction (PSC) (Worley, Powers 2014b). Finally, chemical shift regions containing 
spectral baseline noise or solvent signals were manually removed. Binning of the processed 
NMR spectra was performed using an adaptive intelligent binning algorithm that minimizes 
splitting signals between multiple bins (De Meyer, Sinnaeve, Van Gasse, Tsiporkova, 
Rietzschel, De Buyzere, Gillebert et al. 2008).
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Direct infusion ESI-Q-TOF-MS acquisition and preprocessing
Standard metabolite mixture and E. coli metabolome extracts—The standard 
metabolite mixtures were used to initially optimize DI-ESI-MS source conditions. DI-ESI-
MS data were collected on a Synapt G2 HDMS quadrupole time-of-flight MS instrument 
(Waters, Milford, MA) equipped with an ESI source. All MS experiments were carried out 
at a flow rate of 10 μL/min for 1 min and mass spectra were acquired over a mass range of 
m/z 50 to 1200.
Human dopaminergic neuroblastoma cell extracts—Mass spectra of the SK-N-SH 
samples were acquired in positive ion mode over a mass range of m/z 50 to 1200. Spectra 
were acquired for 0.5 min using the following optimized source conditions: 2.5 kV for ESI 
capillary voltage, 60 V for sampling cone voltage, 4.0 V for extraction voltage, 80 °C for 
source temperature, 250 °C for desolvation temperature, 500 L/h for desolvation gas, and 15 
μL/min flow rate of injection.
The initial stages of mass spectral data processing were performed using MassLynx V4.1 
(Waters Corp., Milford, MA). A background subtraction was performed on all spectra 
(Figure 1B): reference spectra of either paraquat, MPP+, rotenone, or 6-OHDA in ddH2O/
methanol/FA (49.75:49.75:0.5) at 10 ppm were used as backgrounds. Background 
subtraction of each spectrum was performed in a class-dependent manner (e.g. the MPP+ 
MS reference spectrum was used as background for MPP+ treated cells). As a result, mass 
spectral signals from the drugs themselves are guaranteed to not influence subsequent 
analyses. The background-subtracted mass spectra were then loaded into MVAPACK for 
binning and normalization. All mass spectra were linearly re-interpolated onto a common 
axis that spanned from m/z 50 to 1200 in 0.003 m/z steps, resulting in 383,334 variables 
prior to processing. Based on the low probability of observing a metabolite in the mass 
range m/z 1100 to 1200 (Figure S1), the region was removed prior to binning. Mass spectra 
were uniformly binned using a bin width of 0.5 m/z, resulting in a data matrix of 2,095 
variables. Finally, the MS data matrix observations were normalized using probabilistic 
quotient (PQ) normalization (Dieterle, Ross, Schlotterbeck, Senn 2006).
Multivariate statistical analysis
Using functions available in the latest version of MVAPACK, the NMR and mass spectral 
data were joined into a single multiblock data structure and modeled using MB-PCA and 
MB-PLS. More specifically, the CPCA-W algorithm (Westerhuis, Kourti, Macgregor 1998) 
was used to generate the MB-PCA model. MB-PLS with super-score deflation (Westerhuis, 
Coenegracht 1997) was used to generate the MB-PLS model. Both blocks were scaled to 
unit variance prior to modeling, and equal contribution of each block to the models 
(fairness) was ensured by further scaling each block by the square root of its variable count 
(Smilde, Westerhuis, de Jong 2003). For the purposes of comparison, PCA and PLS models 
of the independent NMR and MS data matrices were also constructed. All PLS models were 
trained on a binary discriminant response matrix (i.e., PLS-DA), in which untreated cells 
were assigned to one class and all drug-treated cells were assigned to a second class.
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Cross validation of multivariate models
All PCA and MB-PCA models were cross-validated using a leave-one-out (LOOCV) 
procedure in MVAPACK during model fitting (Lei, Zavala-Flores, Garcia-Garcia, 
Nandakumar, Huang, Madayiputhiya, Stanton et al. 2014). PLS-DA and MB-PLS-DA 
models were cross-validated using a Monte Carlo leave-n-out (MCCV) procedure (Bove, 
Prou, Perier, Przedborski 2005). The results of cross-validation were summarized by per-
component Q2 values, where the number of model components was chosen such that 
cumulative Q2 was a strictly increasing function of component count. Response permutation 
tests of all supervised models were performed with 1,000 permutations each to assess the 
statistical significance of model R2Y and Q2 values (Kamel, Hoppin 2004). CV-ANOVA 
significance tests (Eriksson, Trygg, Wold 2008) were also performed to supplement the 
results of the permutation tests. Results of all permutation tests, along with cross-validated 
scores plots of all supervised models, are provided in the supplementary information 
(Figures S6–S11).
Metabolite identification by DI-ESI-MS and MS/MS
Metabolite identifications were achieved by obtaining accurate m/z and further verified 
using MS/MS experiments. A modified static mode nano-electrospray ionization (nESI) 
source was used for metabolite identification. Samples were loaded into home-pulled 
borosilicate emitters fabricated from PYREX 100 mm capillary melting point tubes 
(Corning, Tewksbury, MA, USA). Emitters were pulled with a vertical micropipette puller 
(David Kopf Instruments, Tujunga, CA, USA). Each emitter was examined under a 
microscope (American Optical Company, Buffalo, NY, USA) in order to maintain 
reproducible tip geometries. The capillary was filled with a metabolite extract and placed in 
a home-made sprayer mounted to the Synapt G2 nESI source XYZ stage such that the 
capillary potential was applied by a platinum wire in direct contact with the sample solution.
The optimum nESI source parameters were slightly different from those of the normal DI-
ESI source. The nESI source parameters were as follows: capillary spray voltage 1.20 kV, 
sampling cone voltage 40 V, extraction voltage 5 V, and source temperature 80 °C. Spectra 
were collected for 2 min in positive ion mode over a mass range of m/z 50 to 1200. MS/MS 
collision energies (CE) were optimized for each metabolite to yield maximum 
fragmentation. Mass calibration of the instrument was performed by external calibration 
with sodium acetate, which was infused under the same conditions as the samples. The mass 
signals of sodium acetate cluster ions (having the general formula [(C2H3O2Na)n + Na]+) 
occur every m/z 82.0031. Such cluster ions were used to externally calibrate the instrument 
from m/z 104.9928 (n = 1 cluster) to m/z 1171.0328 (n = 14 cluster). All metabolite spectra 
were smoothed, centroided, and internally mass corrected relative to the [M+H]+ ion for 
reserpine (m/z 609.2812) using MassLynx V4.1. Accurate m/z values were searched against 
the following online metabolite MS databases: Human Metabolome Database (HMDB, 
http://www.hmdb.ca/, 41,514 metabolites) (Wishart, Jewison, Guo, Wilson, Knox, Liu, 
Djoumbou et al. 2013; Wishart, Knox, Guo, Eisner, Young, Gautam, Hau et al. 2009; 
Wishart, Tzur, Knox, Eisner, Guo, Young, Cheng et al. 2007) and the general Metabolite 
and Tandem MS Database (METLIN, http://metlin.scripps.edu, 242,766 metabolites) 
(Smith, O’Maille, Want, Qin, Trauger, Brandon, Custodio et al. 2005) with a threshold 
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window of 20 ppm. The wide window was used to guarantee a thorough search, but a more 
stringent mass tolerance (~ 1 ppm) was used when making the final assignment.
RESULTS AND DISCUSSION
Optimization of Metabolomics Sample Preparation and MS Source Conditions
Acquisition of DI-ESI-MS data of the highest reliability, reproducibility and information 
content necessitated the identification of instrumental parameters that yielded maximal ion 
transmission efficiency. Using a standard metabolite mixture, we first optimized several 
critical ion source conditions, namely: SCV, ECV, desolvation temperature, desolvation gas 
flow rate, and cone gas flow rate. Each parameter was sequentially optimized by 
systematically varying its setting within a predefined range and searching for a maximum 
ion intensity based on the sum of all detectable spectral signal intensities. After an optimal 
setting was identified, the parameter value was held fixed while the next parameter was then 
varied. The process was repeated until an optimized setting was achieved for all five source 
parameters.
Initial optimization using the standard metabolite mixture indicated that changes to the SCV 
setting had the largest impact on ion transmission. Ion intensities increased from 5.18 × 103 
to 2.69 × 105 for β-alanine, 1.83 × 104 to 1.39 × 106 for glutamine, 1.41 × 105 to 5.46 × 106 
for L-histidine, 1.28 × 104 to 6.84 × 106 for caffeine, and 7.21 × 103 to 7.26 × 105 for L-
asparagine as the SCV was reduced from 100 V to 20 V. Ibuprofen was not observed in any 
of the mass spectra. Changes to all of the other source parameters were found to have a 
minimal impact on ion intensity: no other parameter increased the ion intensities by more 
than a factor of five. For example, the ion intensity only varied from 7.21 × 105 to 3.03 × 
105 for caffeine when the desolvation gas flow was changed from 500 L/h to 1000 L/h. The 
optimal source parameters for the standard metabolite mixture were determined to be: SCV 
of 40 V, ECV of 6.0 V, desolvation temperature of 150 °C, desolvation gas flow of 500 L/h, 
and a cone gas flow of 0 L/h.
Further optimization of the SCV and ECV settings was pursued by applying DI-ESI-MS to a 
biological matrix of metabolites extracted from Mach1 E. coli. Three compounds from the 
cellular extract were randomly selected based on their equal distribution within the typical 
mass range (m/z 50 to 1200) of known metabolites. These three compounds had molecular 
ion peaks corresponding to m/z 118.09, m/z 437.21, and m/z 704.53. The impact of ECV on 
ion intensity was tested over a range of 2.0 to 10 V, which identified an optimal ECV of 4.0 
V. Importantly, the ion intensity of these selected molecular ion peaks were not significantly 
affected by varying ECV. ECV values optimized against the standard metabolite mixture 
and the E. coli cellular extract were found to be equivalent to within experimental error. The 
impact of SCV on ion intensity was also tested using E. coli cellular extracts. SCV was 
varied over a range of 20 to 100 V (Figure S2A), which identified an optimal SCV range of 
40 to 60 V by examining a subset of ion peak intensities corresponding to m/z 118.09, m/z 
437.21, and m/z 704.53 (Figure S2B). An SCV of 40 V, consistent with the value obtained 
with the standard metabolite mixture, was found to maximize the total information content 
because intense signals were observed for all metabolites.
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Although ion intensity is also positively correlated with metabolite concentrations, simply 
injecting a highly concentrated metabolite sample may increase the likelihood of ion 
suppression (Annesley 2003; Skazov, Nekrasov, Kuklin, Simenel 2006) due mostly to 
increased salt concentrations. The signals from low-mass and polar compounds are more 
likely to be suppressed by other metabolites as the total sample concentration increases. It 
was therefore necessary to determine an optimal sample size for DI-ESI-MS analysis of 
metabolomics samples in order to maximize both ion intensity and information content. E. 
coli cellular extracts that were optimized to maximize signal intensity in NMR-based 
metabolomics (Zhang, Halouska, Gaupp, Lei, Snell, Fenton, Barletta et al. 2013) were used 
to determine the optimal sample size for DI-ESI-MS. A mass spectrum (Figure S3A) was 
collected for a series of sample dilutions (1:10, 1:25, 1:50, and 1:100) in ddH2O/
methanol/FA (49.75:49.75:0.5). For each dilution factor, the total number of spectral peaks 
above the noise threshold was calculated (Figure S4) and the relative intensities of molecular 
ion peaks at m/z 118.09, 437.21, and 705.53 were monitored. A bar graph summarizing 
these results is presented in Figure S3B. More spectral signals and higher signal intensities 
for the three monitored molecular ions were observed for the 10x sample relative to all the 
other dilution factors. Thus, a ten-fold dilution of a metabolomics sample previously 
optimized for 1D 1H NMR experiments was deemed suitable for DI-ESI-MS in our 
combined MS and NMR metabolic fingerprinting protocol. Put simply, a single sample may 
be prepared and split for NMR and MS analysis, where the preparation of the MS-bound 
sample only requires a ten-fold dilution into a compatible solvent, such as ddH2O/
methanol/FA (49.75:49.75:0.5).
NMR and MS data pretreatment
Data preprocessing and pretreatment are critical components of any multivariate statistical 
analysis and have been extensively reviewed (Worley, Powers 2013). Our protocols for 
NMR data preprocessing have been previously reported (Halouska, Powers 2006; Zhang, 
Halouska, Gaupp, Lei, Snell, Fenton, Barletta et al. 2013; Zhang, Halouska, Schiaffo, 
Sadykov, Somerville, Powers 2011) and were utilized as a basis for NMR data handling.
A minimalistic set of pretreatment steps was pursued for both NMR and MS data matrices. 
To decrease the time required for computing PCA models, NMR spectra were AI-binned 
(De Meyer, Sinnaeve, Van Gasse, Tsiporkova, Rietzschel, De Buyzere, Gillebert et al. 2008) 
and mass spectra were uniformly binned in preparation for PCA. The data were then 
normalized to correct for random errors in dilution factors or experimental parameters. 
Binned NMR and mass spectra were normalized using Standard Normal Variate (SNV) and 
Probabilistic Quotient (PQ) normalization methods, respectively (Dieterle, Ross, 
Schlotterbeck, Senn 2006). Full-resolution NMR spectral data was used for PLS, which 
permitted the creation of backscaled pseudo-spectral loadings that greatly enhance model 
interpretability (Cloarec, Dumas, Craig, Barton, Trygg, Hudson, Blancher et al. 2005; 
Cloarec, Dumas, Trygg, Craig, Barton, Lindon, Nicholson et al. 2005). However, because 
the full-resolution mass spectral data matrix contained over 300,000 variables, binned mass 
spectra were used in PLS modeling to reduce computation time. While the NMR spectra 
were binned to mask chemical shift variations that reduce the effectiveness of PCA, binning 
of the mass spectra was performed solely to decrease the time required for model 
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computation. For the mass spectral data, a uniform bin width of 0.5 m/z was used based on 
the mass distribution of all metabolites cataloged in the HMDB (Figure S1). As noise is 
known to decrease the interpretability of scores (Halouska, Powers 2006), all spectral 
regions found by manual inspection to contain only baseline noise were removed prior to 
modeling. The final NMR data matrices for PCA and PLS contained 159 and 16,138 
variables, respectively. Likewise, the MS data matrix contained 2,095 (PCA and PLS) 
variables.
Despite the marked reduction in MS variable count incurred from uniform binning, the 
resulting binned data matrix retained enough information to differentiate signals arising 
from distinct metabolites. Based on available data of accurate m/z of metabolites in the 
HMDB, 85% of metabolites have an m/z difference with their “neighbor” metabolites (the 
metabolites with the closest m/z) greater than 0.5 m/z (Figure S1). Also, the number of 
metabolites identified from a direct-infusion MS analysis of cell extracts generally ranges 
from 200 to 400 metabolites (Draper, Lloyd, Goodacre, Beckmann 2014), which would be 
divided over 2,095 bins. This implies that on average the 0.5 m/z bin size would be expected 
to capture no more than one mass isotopic distribution or one metabolite per bin.
Classical PCA and PLS modeling
PCA of the binned NMR data matrix (N = 29, K = 159) resulted in 10 principal components 
having cumulative R2X (degree of fit) and Q2 (predictive ability) metrics of 0.95 and 0.46, 
respectively. Overall, no patterns were readily discernable in the NMR PCA scores (Figure 
2A) due to high within-class variation in the data. However, scores for paraquat treatment 
were found to significantly separate from all other classes (p < 0.002) along PC1 (Worley, 
Halouska, Powers 2013). Scores from PCA of the binned MS data matrix (N = 29, K = 
2,095) were found to exhibit markedly less within-class variation compared to the NMR 
data (Figure 2B). Three significant components were identified from the binned MS data, 
yielding fairly low cumulative R2X and Q2 metrics of 0.34 and 0.16. While paraquat 
treatment still separated from other drug treatments in MS PCA scores space, the greatest 
separations were observed between treated and untreated cells (p < 1.5 × 10−9). These 
differing patterns of separation in NMR and MS PCA scores suggested that multiblock 
analyses could provide further information, ideally separating both control and paraquat 
scores from all other classes.
PLS-DA of the full-resolution NMR (N = 29, K = 16,138) and MS (N = 29, K = 2,095) data 
matrices both resulted in two-component models. With the exception of the algorithmically 
forced separation between control and treatment classes, similar clustering patterns were 
observed when compared to the PCA scores. Leave-n-out cross-validation metrics from the 
NMR (R2Y = 0.92, Q2 = 0.64) and MS (R2Y = 0.99, Q2 = 0.93) PLS-DA models indicated 
reasonable levels of fit and predictive ability. Further validation by CV-ANOVA (Eriksson, 
Trygg, Wold 2008) indicated reliable models with p values of 1.5 × 10−6 and 2.9 × 10−15 for 
NMR and MS data, respectively. Response permutation tests for both PLS-DA models 
returned p values equal to zero, supporting the CV-ANOVA significance test results.
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Multiblock PCA and PLS modeling
Identification of consensus directions in the NMR and MS data matrices that maximally 
captured data matrix variations (MB-PCA) or data-response correlations (MB-PLS) resulted 
in more informative models than those calculated against either NMR or MS in vacuo. 
Using MB-PCA, five significant components were identified (Q2 = 0.23) that cumulatively 
explained comparable amounts of variation in the NMR (R2X = 0.85) and MS (R2X = 0.50) 
blocks relative to the individual PCA models. As expected, MB-PCA combined the 
information from both blocks to dramatically increase class separations in super-scores 
space (Figure 2C). More specifically, both control and paraquat classes were separated from 
other drug treatments, predominantly along PC1. Furthermore, MPP+ treatment exhibited 
significant separation from 6-OHDA and Rotenone treatments, which was not expected 
from examination of the individual NMR or MS PCA scores.
MB-PLS of the data yielded similar improvements in model information content. Two 
significant components were identified (R2Y = 0.98, Q2 = 0.89) that clearly separated 
untreated and paraquat treatment classes from all other classes in scores space. CV-ANOVA 
testing resulted in a p value of 1.7 × 10−12 and response permutation testing yielded a p 
value equal to zero, indicating a reliable MB-PLS-DA model.
Metabolite identification by combining NMR, accurate mass and MS/MS
Identification of key metabolites from a metabolomics sample is undoubtedly a nontrivial 
undertaking. The difficulties of metabolite assignment are further compounded by spectral 
overlap present in both 1D 1H NMR and DI-ESI-MS data. However, the combination of 
these two complementary forms of spectral information may aid in overcoming the 
ambiguities encountered during assignment. The ability of our approach to aid in metabolite 
identification was demonstrated using NMR and MS data obtained from the treatment of 
human dopaminergic neuroblastoma cells with known neurotoxic agents.
A first-pass identification of biologically important metabolites was performed by 
examination of the backscaled NMR block loadings from MB-PLS-DA (Figure 3A). 1H 
NMR chemical shifts of loading ‘signals’ that contributed significantly to class separation 
were used to query theHuman Metabolome Database (HMDB) (Wishart, Jewison, Guo, 
Wilson, Knox, Liu, Djoumbou et al. 2013) for matching metabolites. To confirm the NMR 
results, accurate mass and MS/MS experiments were performed, guided by information 
obtained from the backscaled MS block loadings (Figure 3B). Effectively, the MB-PLS-DA 
MS block loadings identified specific masses to pursue for more focused and detailed 
analyses. For accurate mass measurements, reserpine was used as an internal m/z reference, 
because it is located in a region containing a minimal number of known metabolites and it 
can be ionized in both positive and negative modes. Accurate masses were used to conduct 
elemental composition analyses with MassLynx 4.1 based on a restricted list of elements (C, 
H, O, N, P, S, Na and K), resulting in a set of possible molecular formulas and associated 
compounds. Metabolite assignments consistent with both accurate mass and NMR chemical 
shifts were retained for further study by collision-induced dissociation MS/MS. It is 
noteworthy that many compounds were identified as sodium adducts, which is expected for 
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DI-ESI-MS (Lin, Yu, Yan, Hang, Zheng, Xing, Huang 2010), particularly when sample 
purification steps have been kept to a minimum.
As an illustration, examination of backscaled MS block loadings identified a significantly 
increased mass spectral signal at m/z 203.0534. This accurate mass is consistent with the 
molecular formula C6H12O6Na (theoretical exact m/z = 203.0532) to within 1 ppm. The 
corresponding potassium adduct of C6H12O6 was also observed at m/z 219.0266, which is 
within 2.5 ppm of theoretical exact m/z 219.0271. The molecular ion peak m/z 203.0534 was 
selected for further examination by MS/MS using collision-induced dissociation, which 
yielded product ions of m/z 123, 141, and 159, among others (Figure 4). These three peaks 
were assigned to [C6H12O6-CO2+Na]+, [C6H12O6-CO2-H2O+Na]+ and [C6H12O6-
CO2-2H2O+Na]+ respectively. Together with the elemental composition suggested by 
accurate mass measurement, the neutral losses of CO2 and multiple H2O indicate a 
likelihood that the precursor ion was a polyhydroxy carboxylic acid. Possible structures are 
inset in Figure 4. Using these procedures, our NMR analysis of human dopaminergic 
neuroblastoma cells treated with paraquat identified an increase in metabolites associated 
with the Pentose Phosphate Pathway (PPP) (Lei, Zavala-Flores, Garcia-Garcia, 
Nandakumar, Huang, Madayiputhiya, Stanton et al. 2014).
CONCLUSIONS
We report an optimized protocol for combining 1D 1H NMR and DI-ESI-MS datasets for 
the purposes of high-throughput metabolic fingerprinting and profiling. By splitting 
metabolite extracts optimized for NMR acquisition and diluting the MS-bound aliquots ten-
fold in H2O/methanol/FA (49.57:49.75:0.5), we obtained samples suitable for direct infusion 
electrospray ionization, thus avoiding the use of pre-source chromatographic separations. 
We also optimized several DI-ESI-MS ion source conditions in order to maximize the 
quality of the MS metabolomics data. The optimal source parameters were determined to be: 
SCV of 40 V, ECV of 4.0 V, desolvation temperature of 150 °C, desolvation gas flow of 
500 L/h, and a cone gas flow of 0 L/h. The acquired mass spectra were preprocessed with 
background subtraction, followed by uniform binning with a 0.5 Da bin size and spectral 
noise region removal. Using multiblock bilinear factorization algorithms that capitalize on 
the availability of blocking information, we achieved greater levels of model interpretability 
with the NMR and MS data than available from single-block PCA and PLS methods. We 
also demonstrated the combined use of NMR and MS/MS data for the rapid and accurate 
identification of metabolites significantly perturbed in backscaled MB-PLS-DA loadings. In 
summary, we present a unique means of increasing metabolome coverage in a high 
throughput manner by leveraging the complementary information provided by MS and 
NMR, without the encumbrances and liabilities of pre-source chromatographic separations. 
Our protocol for using combined NMR and MS metabolomics data was successfully 
demonstrated on a study examining the impact of neurotoxins known to induce 
dopaminergic cell death, an important model relevant to Parkinson’s disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
A flow chart illustrating our protocol for combining NMR and MS datasets for 
metabolomics. A) 2.0 mL of a single metabolite extract was split into 1.8 mL and 0.2 mL for 
NMR and MS analysis, respectively. B) Spectral binning of the NMR data used adaptive 
intelligent binning. First, the background is subtracted from the MS spectrum followed by 
spectral binning. Spectral binning of the MS data used fixed binning with a set bin width of 
0.5 m/z. C) Baseline noise removal and normalization separately applied to the NMR and 
MS data sets. D) The NMR and MS datasets were modeled by MB-PCA and MB-PLS. E) 
The resulting block scores and loadings were analyzed for significantly contributing 
metabolites.
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Figure 2. 
Scores generated from (A) PCA of 1H NMR in vacuo, (B) PCA of DI-ESI-MS in vacuo, and 
(C) MB-PCA of 1H NMR and DI-ESI-MS. Separations between classes are greatly 
increased upon combination of the two datasets via MB-PCA. Symbols designate the 
following classes: Control ( ), Rotenone ( ), 6-OHDA ( ), MPP+ ( ), and Paraquat 
( ).Corresponding dendrograms are shown in (D–F). The statistical significance of each 
node in the dendrogram is indicated by a p value (Worley, Halouska, Powers 2013).
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Figure 3. 
Backscaled MB-PLS-DA first component loadings generated from (A) the 1H NMR block 
and (B) the DI-ESI-MS block that compare control with drug treatment. The peaks in the 
loadings are labeled with the same colored symbol (1H NMR, square; MS, circle) and were 
assigned to the following metabolites: lactate ( ), glutamate ( ), hexose ( ), citrate ( ), 
heptose ( ), hexose ( ), phosphoaspartate ( ), and an ambiguous metabolite ( ).
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Figure 4. 
Direct injection static-nESI-MS/MS CID spectrum of m/z 203. Fragment ions at m/z 123, 
141, and 159 are consistent with a polyhydroxy carboxylic acid, such as 2-deox-gluconate or 
fuconate (inset). A complete assignment of all peaks to the putative structure(s) was not 
possible, most likely due to selection of multiple multiple isobaric and / or isomeric species 
prior to dissociation.
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Figures S6 - S8. PLS-DA and MB-PLS-DA cross-validated scores for NMR, MS and combined 
datasets. 
Figures S9 – S11. Response permutation test results for NMR, MS and combined PLS-DA and 
MB-PLS-DA models. 
  
SUPPLEMENTARY METHODS 
Preparation of standard bacterial metabolomics samples 
Escherichia coli Mach1 starter culture was grown at 37
 
°C in LB media. The culture was shaken 
at 200 rpm for 12 hours and grown to an approximate O.D.600 of 12.0. Then 1 mL of the starter 
culture was added to three 250 mL flasks containing 25 mL of LB media at 37
 
°C. The bacteria 
were allowed to grow to a stationary growth phase (6 h) with an O.D.600 of 10.75. E .coli cells 
were then harvested by transferring 5 mL from each 250 mL flask to three corresponding 15 mL 
falcon tubes, centrifuged for 10 min at 2057 g at 25 °C. The supernatant media was discarded. 
After two washing steps with PBS, the supernatant was discarded and the cell pellets were 
washed with 10 mL of cold distilled water three times. The cell pellets were re-suspended with 1 
mL of distilled water and transferred to 1.6 mL microcentrifuge tubes and centrifuged at 15,294 
g for 5 minutes at 25 °C. The cell pellets were then lysed with a Sonic Dismembrator model 100 
(Fisher Scientific) for 5 minutes, then centrifuged for 10 minutes at 15,294 g at 25 °C. 700 µL of 
the metabolite extract was transferred to a second 1.6 mL microcentrifuge tube. Another 
extraction was performed on the remaining cell debris by adding 1.0 mL of 50/50 
ddH2O/methanol to the first microcentrifuge tube, which was then centrifuged for 10 minutes at 
15,294 g at 25 °C. 800 µL of the supernatant was extracted and combined with the initial 700 µL 
extract. The resulting 1.5 mL cell lysate was frozen, lyophilized (Freezone 4.5, Kansas City, 
MO, USA), and then resuspended in 1.0 mL of ddH2O/methanol/FA (49.75:49.75:0.5). To 
generate analytical replicates, each of the three metabolomics samples was separated into 3 
aliquots of 100 μL and then diluted ten-fold with ddH2O/methanol/FA (49.75:49.75:0.5) 
containing 10 μM caffeine as an internal mass reference. 
  
  
Figure S1. Mass distribution of known metabolites from the Human Metabolome Database 
(HMDB, http://www.hmdb.ca/). 
  
  
Figure S2.  The effects of sampling cone voltage on DI-ESI-MS on total ion count for E. coli 
Mach1 metabolite extract. (A) Mass spectra at varying SCVs (B) Intensity change plotted against 
SCV for three spectrometric peaks at m/z 118.09, 437.21, and 704.53. 
  
 Figure S3. (A) DI-ESI-MS spectra of E. coli Mach1 metabolite extract spiked with 
[caffeine+H]
+
 m/z 195.09 and its primary fragment m/z 138.07 (internal mass reference)  at 
various dilutions; H2O/methanol/FA (49.75:49.75:0.5) and 10 µM caffeine (solvent blank), 10 
fold dilution, 50 fold dilution, 100 fold dilution, and 1000 fold dilution. (B) Bar graph of relative 
intensities for 10, 50, 100, 1000 times dilution for three spectrometric peaks at m/z 118.09 (red), 
437.21 (blue), and 704.53 (green) normalized to [caffeine+H]
+
. 
  
  
 
Figure S4. Total number of peaks in the MS spectrum above the noise threshold is plotted as a 
function of dilution factor. 
  
  
 
Figure S5. nano-DI-ESI-MS and 1D 
1
H NMR spectra of control and paraquat treated samples. 
  
 Figure S6. PLS-DA scores computed from single Monte Carlo leave-n-out cross-validation of 
the in vacuo 
1
H NMR dataset. Symbol colors designate the following classes: Control ( ), 
Rotenone ( ), 6-OHDA ( ), MPP+ ( ), and Paraquat ( ). Symbols designate the mean value of 
an observation from all iterations of a Monte Carlo cross-validation, and ellipses designate the 
95% confidence ellipse for the respective observation. 
  
 Figure S7. PLS-DA scores computed from a single Monte Carlo leave-n-out cross-validation of 
the in vacuo DI-ESI-MS dataset. See Figure S6 for color, symbol and ellipse definitions. 
  
 Figure S8. MB-PLS-DA super scores computed from a single Monte Carlo leave-n-out cross-
validation of the combined MS and NMR datasets. See Figure S6 for color, symbol and ellipse 
definitions. 
  
 Figure S9. Response permutation test results for the PLS-DA model of the in vacuo 
1
H NMR 
dataset. Model fit (R
2
) statistics (A) are shown in blue, and model predictive ability (Q
2
) statistics 
are shown in green. True values of R
2
 and Q
2
 are represented by vertical bars, and null 
distributions are computed through kernel density estimation of the values from permutation. 
Scatter plots of the permutation R
2
 and Q
2
 statistics are shown in the lower pane. 
  
 Figure S10. Response permutation test results for the PLS-DA model of the in vacuo DI-ESI-
MS dataset. Model fit (R
2
) statistics (A) are shown in blue, and model predictive ability (Q
2
) 
statistics are shown in green. True values of R
2
 and Q
2
 are represented by vertical bars, and null 
distributions are computed through kernel density estimation of the values from permutation. 
Scatter plots of the permutation R
2
 and Q
2
 statistics are shown in the lower pane. 
  
 Figure S11. Response permutation test results for the MB-PLS-DA model of combined MS and 
NMR datasets. Model fit (R
2
) statistics (A) are shown in blue, and model predictive ability (Q
2
) 
statistics are shown in green. True values of R
2
 and Q
2
 are represented by vertical bars, and null 
distributions are computed through kernel density estimation of the values from permutation. 
Scatter plots of the permutation R
2
 and Q
2
 statistics are shown in the lower pane. 
 
 
 
 
 
